Loading clinical trials...
Loading clinical trials...
The objective of this study is to assess the effectiveness of the glecaprevir/pibrentasvir (GLE/PIB) regimen in adolescent participants aged 12 to \<18 years of age with chronic hepatitis C (CHC) in c...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AbbVie
NCT07388979 · HIV - Human Immunodeficiency Virus, HBV (Hepatitis B Virus), and more
NCT04366973 · Hepatitis C Virus (HCV)
NCT04577482 · Hepatitis C Virus (HCV)
NCT02219490 · Chronic Hepatitis C Virus (HCV) Infection Genotype 1
NCT02167945 · Chronic Hepatitis C Virus (HCV) Infection Genotype 1
Dagestan State Medical University /ID# 218500
Makhachkala, Dagestan, Respublika
A.F.Agafonov Republican Clinical Infectious Hospital /ID# 218498
Kazan', Tatarstan, Respublika
South-Ural Medical State University /ID# 218501
Chelyabinsk
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions